Bentley Systems Named 2018 Microsoft CityNext Partner of the Year
Bentley Systems today announced it has received a 2018 Microsoft Partner of the Year award. Bentley was honored among a global field of top Microsoft partners for demonstrating excellence in innovation and implementation of user solutions based on Microsoft technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180614005982/en/
Awards were announced in 39 categories, with winners chosen from more than 2,600 entrants from 115 countries worldwide. Bentley Systems was recognized for providing outstanding solutions and services in the CityNext Partner of the Year category.
Bentley Systems CEO Greg Bentley said, “We are honored to have received this prestigious award which recognizes Bentley as a provider of cloud-based software solutions powered by Azure, for the advancement of infrastructure projects throughout the world, and specifically for Mass Rapid Transit Corporation’s [MRTC] outstanding Sungai Buloh-Serdang-Putrajaya [SSP] line in Malaysia. MRTC is going digital, harnessing Bentley and Microsoft technology to deliver one of the most ambitious infrastructure projects ever undertaken in Asia.”
With more than 1.7 million people residing in just 94 square miles, Kuala Lumpur, Malaysia has one of the highest population densities globally. As a result, it is estimated that residents living in the Greater Klang Valley region collectively spend 280 million hours per year stuck in traffic. The SSP line is the second line of MRTC’s Klang Valley Mass Rapid Transit railway project, which will create better mobility for residents and make it possible to ease traffic by an estimated 160,000 cars daily. As Malaysia’s largest infrastructure project, the SSP line includes 11 interchange stations, making it easier for commuters to transfer to existing and future rail lines, while 16 stations will have park and ride facilities. In addition to creating an estimated 130,000 new employment opportunities, the line has the potential to generate RM 20 billion in cost savings per year as a result of reduced traffic congestion.
The MRTC project team utilizes Bentley OpenRail’s connected data environment comprising the shared services of ProjectWise and AssetWise, powered by Microsoft Azure to ensure seamless information exchange, real-time collaboration, and management of asset information across the lifecycle, among hundreds of team members.
Poh Seng Tiok, director of planning and design for MRTC noted that on a project of this scale and complexity, it is essential to effectively manage and share the huge amount of data across the entire project—from design and construction, through to operation and asset management.
Mr. Poh said, “We need to make sure that all the different [project] phases are well covered and information that we build up during design, and during construction are taken forward during the operation and maintenance stage for better understanding. By turning to the Bentley/Microsoft cloud-based solution, we are able to streamline collaboration across all teams and identify and mitigate potential issues, before they impact cost, schedule, and safety. We expect to increase productivity by about 35 percent, through reducing design rework by providing real-time, accurate information.”
Through the partnership with Bentley Systems and Microsoft, MRTC expects to complete the project on time and within budget by 2022. Watch the project video here. Learn more about the featured project here.
“Our ecosystem of partners is crucial to delivering transformative solutions, and this year’s winners have proven to be some of the finest among their peers,” said Gavriella Schuster, corporate vice president, One Commercial Partner, Microsoft Corp. “We are pleased to recognize Bentley Systems for being selected as winner of the 2018 Microsoft CityNext award.”
About Microsoft’s Partner of the Year Awards
The Microsoft Partner of the Year Awards recognize Microsoft partners that have developed and delivered exceptional Microsoft-based solutions during the past year. Award winners are recognized at Microsoft Inspire, Microsoft’s annual partner event, to be held this year in Las Vegas, July 15 through 19. Learn more about the awards program.
About Bentley Systems
Bentley Systems is a global leader dedicated to providing engineers, architects, geospatial professionals, constructors, and owner-operators with comprehensive software solutions for advancing infrastructure. Founded in 1984, Bentley has more than 3,500 colleagues in over 50 countries, and is on track to surpass an annual revenue run rate of $700 million. Since 2012, Bentley has invested more than $1 billion in research, development, and acquisitions. www.bentley.com
Bentley, the “B” Bentley logo, AssetWise and ProjectWise are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00 | Pressemelding
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10 | Pressemelding
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13 | Pressemelding
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00 | Pressemelding
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41 | Pressemelding
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00 | Pressemelding
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i